Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂ - Wikidata - wikimedia - TriplyDB

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

http://www.wikidata.org/entity/Q27008521

about

An Update of Microsomal Prostaglandin E Synthase-1 and PGE2 Receptors in Cardiovascular Health and Diseases Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway Platelets and cancer: a casual or causal relationship: revisited.Anti-inflammatory effects of Hwang-Heuk-San, a traditional Korean herbal formulation, on lipopolysaccharide-stimulated murine macrophages.PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.Characterization of microsomal prostaglandin E synthase 1 inhibitors.Microsomal prostaglandin E2 synthase-1 inhibitors: a patent review.Antiinflammatory effects of essential oil from the leaves of Cinnamomum cassia and cinnamaldehyde on lipopolysaccharide-stimulated J774A.1 cells.Aurothiomalate inhibits the expression of mPGES-1 in primary human chondrocytes.Schisandrin A suppresses lipopolysaccharide-induced inflammation and oxidative stress in RAW 264.7 macrophages by suppressing the NF-κB, MAPKs and PI3K/Akt pathways and activating Nrf2/HO-1 signaling.Design, synthesis, and discovery of 5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones and related derivatives as novel inhibitors of mPGES-1.How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.Enhanced Anti-Inflammatory Activities by the Combination of Luteolin and Tangeretin.

P2860

Q28067884-9D293E88-A15E-4505-BBAF-508D536585C4 Q28083349-ED20AD8F-77B8-44AB-9FEE-6F1345A2F778 Q34294719-20492C03-1C78-4675-9CFC-502E7C7F074F Q35876575-B6E904FB-CAE8-451E-B1B0-8B1CB3763EF1 Q36624751-CFDBAB00-98D0-4AB0-AB39-120A316829C6 Q38153792-057D9AED-2CA6-47DB-A854-AFC7BEE12A60 Q39382626-1C9DCC23-687A-4B01-A89B-B00D90A7B17C Q41874626-4848904E-4F03-461C-A2DB-890DCD9F880C Q41919879-872E059A-BDDA-49DB-9341-2C11D594486C Q46266120-6605AA23-F41B-4FCC-A658-C60D045AFB06 Q49886698-ECF10AC9-F248-4855-8D5F-E89A5DE86907 Q52668325-7E8E51A6-93A8-4C52-A212-96F5A962CAF9 Q53119009-38C02BF7-6DA7-4499-90CA-EA5BB208335F

P2860

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

http://www.wikidata.org/entity/Q27008521

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

@ast

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

@en

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

@nl

type

label

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

@ast

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

@en

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

@nl

prefLabel

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

@ast

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

@en

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

@nl

P1433

Q27008521-753E87DB-ABC4-4BFF-8210-77DEBD788A5F

P1476

Q27008521-02362667-C512-46F2-974B-4708EB41462D

P2093

Q27008521-321DC9FD-7E78-4508-92B9-E5D69CF43787

Q27008521-452F41DF-98C2-427C-B208-40508D776843

Q27008521-51EA2008-3BAA-415E-9A62-4876C119D12B

Q27008521-60BB206D-8D9B-49C3-96A3-C937E15F06CD

Q27008521-7C399E8B-13C5-4627-A591-315DD5B45A51

Q27008521-FFEE0436-94D2-4E4F-8FCB-6B84CB2FACEB

P2860

Q27008521-045E38FE-75D4-49B0-BFE0-C0B655F4F6EC

Q27008521-04C71CCF-0888-4101-A08D-88CEF5CA5597

Q27008521-0ACE3B65-5894-4982-83EC-454480CA4795

Q27008521-1908197E-4354-46E5-AD74-ED55EEBCF17C

Q27008521-1B014808-70E9-4E4A-9D59-BD227A7B0C9D

Q27008521-1E9B6A11-FB9B-4E03-BCC6-07571F95ECA4

Q27008521-1F1DA79A-55D1-4BB5-9879-58BE8000A28F

Q27008521-237AB359-BC7C-4731-9BB6-EF1261480E2D

Q27008521-2A85F802-FF33-4AF5-B7DB-7886F3B46AF8

Q27008521-2B6FBDF5-11F2-4DDD-BA6C-3960CBB2FAF2

P304

Q27008521-B801852D-B3FD-46AD-991E-EEFEC239FD71

P31

Q27008521-F52D8316-623A-43F9-A66B-540CC5D90195

P3181

Q27008521-5685A1D0-2E04-465D-A5B1-DCE7215B43BE

P356

Q27008521-BEFFE08C-9127-49E7-87EC-16ED51276FB2

P407

Q27008521-FB886EC7-FE98-463E-A4C6-73CAD18F77F5

P433

Q27008521-DC3881A4-3401-4DFA-91C0-DEC726F311AF

P478

Q27008521-5D45FCC1-1370-473F-AE03-02ACBD56E977

P577

Q27008521-B46E29A1-4EF7-449A-ADC7-334B9B472E77

P698

Q27008521-1ECD4476-22DD-44D7-A6BE-EC378207E0F5

P921

Q27008521-35356BE6-D1D0-48C4-8035-0245BF872DEF

P932

Q27008521-66EED79F-74CD-4D33-A84C-1D771E638BD8

P3181

P356

P1433

Pharmaceutical patent analyst

P1476

Targeting inflammation: multiple innovative ways to reduce prostaglandin E₂

@en

P2093

Earlphia Sells

http://www.w3.org/2001/XMLSchema#string

Emmanuelle J Meuillet

http://www.w3.org/2001/XMLSchema#string

Hui-Hua Chang

http://www.w3.org/2001/XMLSchema#string

Jessica K Norberg

http://www.w3.org/2001/XMLSchema#string

Shuxing Zhang

http://www.w3.org/2001/XMLSchema#string

Srinivas R Alla

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target

15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers

Structural basis for induced formation of the inflammatory mediator prostaglandin E2.

Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase

Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines

Altered eicosanoid levels in human colon cancer

Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer

Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation

P304

265-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4174782

http://www.w3.org/2001/XMLSchema#string

P356

10.4155/PPA.12.90

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24237030

http://www.w3.org/2001/XMLSchema#string

P921

P932

4028977

http://www.w3.org/2001/XMLSchema#string